BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix™, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, announced today that W. James O’Shea, former President and Chief Operating Officer of Sepracor Inc., has been elected to Ocular’s Board of Directors.
Help employers find you! Check out all the jobs and post your resume.
